Xiao-ming Zhou,1 Lan He,2 Gang Hou,3 Bing Jiang,4 Yuan-he Wang,5 Li Zhao1 1Department of Respiratory Medicine, The Shengjing Hospital of China Medical University, Shenyang, People’s Republic of China; 2Department of Microbiology, The Chinese University of Hong Kong, Hong Kong SAR, People’s Republic of China; 3Department of Respiratory Medicine, 4Department of Ultrasonography, The First Hospital of China Medical University, Shenyang, People’s Republic of China; 5Department of Medical Oncology, Liaoning Cancer Hospital, Shenyang, People’s Republic of ChinaBackground: Emerging evidence indicates that C-X-C chemokine receptor type 4 (CXCR4) is a candidate oncogene in several types of human tumor...
CXC chemokine receptor type 4 (CXCR4) plays a prominent role in cancer progression and metastasis. H...
Adjuvant chemotherapy is commonly indicated in lung cancer patients undergoing surgical therapy beca...
Background: This study was conducted to provide an updated estimate of the prognostic power of C-X-C...
Changyuan Zhang,1,* Jie Li,2,* Yi Han,3 Jian Jiang4 1Department of Cardiothoracic Surgery, Inner Mo...
Background: The expression of CXCR4 has been implicated in metastatic dissemination in different mod...
BackgroundThe CXC chemokine, CXCL12, and its receptor, CXCR4 promote metastases of a variety of soli...
ObjectivesAlthough the chemokine CXCL12 and its receptor CXCR4 have been implicated in metastasis of...
PURPOSE: The prognostic value of aberrant C-X-C chemokine receptor type 4 (CXCR4) levels in NSCLC ha...
The stromal-derived factor 1alpha (CXCL12)/chemokine receptor CXCR4 system plays an important role i...
BackgroundIt has been proposed that the chemokine receptor, CXCR4, and its ligand, stromal cell-deri...
Lung cancer is the most common type of cancer in the world and about 1 million people die from lung ...
Fei Hu, Lin Miao, Yu Zhao, Yuan-Yuan Xiao, Qing XuDepartment of Medical Oncology, Shanghai Tenth Peo...
Kongju Wu,1,* Shengnan Yu,2,* Qian Liu,2 Xianguang Bai,1 Xinhua Zheng,1 Kongming Wu2 1Medical Schoo...
IntroductionEvidence suggests that the expression of certain cytokine receptors increases with lung ...
Lung cancer is the second most common malignancy. Unfortunately, despite advances in multimodality t...
CXC chemokine receptor type 4 (CXCR4) plays a prominent role in cancer progression and metastasis. H...
Adjuvant chemotherapy is commonly indicated in lung cancer patients undergoing surgical therapy beca...
Background: This study was conducted to provide an updated estimate of the prognostic power of C-X-C...
Changyuan Zhang,1,* Jie Li,2,* Yi Han,3 Jian Jiang4 1Department of Cardiothoracic Surgery, Inner Mo...
Background: The expression of CXCR4 has been implicated in metastatic dissemination in different mod...
BackgroundThe CXC chemokine, CXCL12, and its receptor, CXCR4 promote metastases of a variety of soli...
ObjectivesAlthough the chemokine CXCL12 and its receptor CXCR4 have been implicated in metastasis of...
PURPOSE: The prognostic value of aberrant C-X-C chemokine receptor type 4 (CXCR4) levels in NSCLC ha...
The stromal-derived factor 1alpha (CXCL12)/chemokine receptor CXCR4 system plays an important role i...
BackgroundIt has been proposed that the chemokine receptor, CXCR4, and its ligand, stromal cell-deri...
Lung cancer is the most common type of cancer in the world and about 1 million people die from lung ...
Fei Hu, Lin Miao, Yu Zhao, Yuan-Yuan Xiao, Qing XuDepartment of Medical Oncology, Shanghai Tenth Peo...
Kongju Wu,1,* Shengnan Yu,2,* Qian Liu,2 Xianguang Bai,1 Xinhua Zheng,1 Kongming Wu2 1Medical Schoo...
IntroductionEvidence suggests that the expression of certain cytokine receptors increases with lung ...
Lung cancer is the second most common malignancy. Unfortunately, despite advances in multimodality t...
CXC chemokine receptor type 4 (CXCR4) plays a prominent role in cancer progression and metastasis. H...
Adjuvant chemotherapy is commonly indicated in lung cancer patients undergoing surgical therapy beca...
Background: This study was conducted to provide an updated estimate of the prognostic power of C-X-C...